glatiramer
Generic: GLATIRAMER ACETATE·Brand: COPAXONE, GLATIRAMER ACETATE, GLATOPA
glatiramer: 2 clinical trials tracked.
glatiramer evidence translation
What we can confirm
2 tracked trials
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about glatiramer, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 2 study sponsors
Related indications
Study sponsors
Clinical Trials (2)
Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Primary endpoint: Number of Major Congenital Malformations (MCMs)
Observational1,178 targetStarted 2021-09Completion 2031-011 site · United StatesBiogen
A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Paediatric Patients With Relapsing Remitting Multiple Sclerosis (RRMS) With Disease Activity on Prior Disease Modifying Therapy (DMT)
Primary endpoint: Brain Magnetic Resonance Imaging (MRI) Assessment: Adjusted Number of New or Enlarged T2 Lesions Per Month
Interventionalopen16 enrolledStarted 2017-10Completion 2025-0913 sites · France, Italy, Poland, Russia…Genzyme, a Sanofi Company